University of Southern California
A first-of-its-kind clinical trial from Keck Medicine of USC will investigate if immunotherapy administered at home can achieve the same outcomes as in-clinic therapy.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
